3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Glioblastoma
40
Carcinoma, Non-Small-Cell Lung
22
Head and Neck Neoplasms
20
Brain Neoplasms
12
Squamous Cell Carcinoma of Head and Neck
11
Glioma
11
Lung Neoplasms
8
Carcinoma, Squamous Cell
8
Breast Neoplasms
8
Astrocytoma
8
Rectal Neoplasms
7
Neoplasms
7
Prostatic Neoplasms
6
Mucositis
5
Esophageal Neoplasms
5
Carcinoma
4
Neoplasm Metastasis
3
Esophageal Squamous Cell Carcinoma
3
Colorectal Neoplasms
3
Xerostomia
2
Stomatitis
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Pancreatic Neoplasms
2
Neoplasms, Squamous Cell
2
Lymphoma
2
Leukemia
2
Laryngeal Diseases
2
Gliosarcoma
2
Adenocarcinoma Of Esophagus
2
Adenocarcinoma
2
Interventions
pertuzumab
1
pazopanib
1
decitabine and cedazuridine drug combination
1
daratumumab
1
Trastuzumab
1
Surgical Procedures, Operative
1
Sunitinib
1
Sorafenib
1
Radiotherapy
1
Opdualag
1
Nivolumab
1
Injections, Subcutaneous
1
Ado-Trastuzumab Emtansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Patient Preference
×
Radiotherapy
×
Clear all
NCT05415215
2026-02-10
ProHer
Hoffmann-La Roche
Phase 3
Completed
346 enrolled
20 charts